Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Ulcerative Colitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06100289
What this trial is testing

Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 70
Testing effectiveness (Phase 2)Study completedNCT00572585
What this trial is testing

Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT03675477
What this trial is testing

A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
Reistone Biopharma Company Limited 164
Large-scale testing (Phase 3)Looking for participantsNCT06937086
What this trial is testing

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Who this might be right for
Ulcerative ColitisObesity or Overweight
Eli Lilly and Company 350
Large-scale testing (Phase 3)Study completedNCT04630028
What this trial is testing

Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 112
Testing effectiveness (Phase 2)UnknownNCT05907330
What this trial is testing

Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Curacle Co., Ltd. 45
Large-scale testing (Phase 3)Study completedNCT03653026
What this trial is testing

The Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 522
Testing effectiveness (Phase 2)WithdrawnNCT02913508
What this trial is testing

Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda
Testing effectiveness (Phase 2)Study completedNCT04577794
What this trial is testing

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Lakefront Biotherapeutics NV 31
Testing effectiveness (Phase 2)Looking for participantsNCT07186101
What this trial is testing

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 252
Testing effectiveness (Phase 2)Study completedNCT04613518
What this trial is testing

The Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Bristol-Myers Squibb 38
Large-scale testing (Phase 3)Study completedNCT03945188
What this trial is testing

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Arena Pharmaceuticals 433
Testing effectiveness (Phase 2)Study completedNCT04996797
What this trial is testing

Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Who this might be right for
Ulcerative Colitis
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 178
Testing effectiveness (Phase 2)UnknownNCT03609905
What this trial is testing

Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Liaocheng People's Hospital 50
Not applicableLooking for participantsNCT06095596
What this trial is testing

Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Sixth Affiliated Hospital, Sun Yat-sen University 334
Not applicableStudy completedNCT04799496
What this trial is testing

Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis

Who this might be right for
Inflammatory Bowel DiseasesColitis, UlcerativeCrohn Disease
Takeda 688
Not applicableUnknownNCT05735665
What this trial is testing

Comparison Between Bowel Ultrasound-based Treat to Target Versus Routine Treat to Target Strategies in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis Chronic ModerateUlcerative Colitis Chronic Severe
IRCCS San Raffaele 250
Testing effectiveness (Phase 2)Looking for participantsNCT07513181
What this trial is testing

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative ColitisInflammatory Bowel DiseasesAutoimmune Diseases
Athos Therapeutics Inc 120
Not applicableLooking for participantsNCT07385131
What this trial is testing

Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

Who this might be right for
Inflammatory Bowel Disease (IBD)CD - Crohn's DiseaseUC - Ulcerative Colitis
Second Affiliated Hospital, Zhejiang University, School of Medicine 300
Post-approval studies (Phase 4)Study completedNCT02318667
What this trial is testing

Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).

Who this might be right for
Colitis, Ulcerative
Merck Sharp & Dohme LLC 38
Next Page